2020
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management
BRODSZKI, Nicholas, Ashley FRAZER-ABEL, Anete S. GRUMACH, Anete S. KIRSCHFINK, Jiří LITZMAN et. al.Základní údaje
Originální název
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management
Autoři
BRODSZKI, Nicholas (752 Švédsko), Ashley FRAZER-ABEL (840 Spojené státy), Anete S. GRUMACH (76 Brazílie), Anete S. KIRSCHFINK (276 Německo), Jiří LITZMAN (203 Česká republika, domácí), Elena PEREZ (840 Spojené státy), Mikko R. J. SEPPANEN (246 Finsko), Kathleen E. SULLIVAN (840 Spojené státy) a Stephen JOLLES (826 Velká Británie a Severní Irsko, garant)
Vydání
Journal of Clinical Immunology, New York, Springer, 2020, 0271-9142
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 8.317
Kód RIV
RIV/00216224:14110/20:00116025
Organizační jednotka
Lékařská fakulta
UT WoS
000516182000001
Klíčová slova anglicky
Complement; complement deficiencies; classical pathway; alternative pathway; mannan-binding lectin
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 17. 7. 2020 09:41, Mgr. Tereza Miškechová
Anotace
V originále
This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for similar to 5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.